Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

  • There is currently no data for MHC

Cond Subscription-Update re HMRC Advance Assurance

17 Feb 2021 07:00

RNS Number : 3090P
MyHealthChecked PLC
17 February 2021
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MyHealthChecked plc

("MyHealthChecked" or "the Company")

 

Conditional Subscription - Update re HMRC Advance Assurance

 

Further to the announcements of 29 January 2021, MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces it has now received Advance Assurance from HM Revenue and Customs that the ordinary shares to be issued are eligible for relief under the Enterprise Investment Scheme. This fulfils one of the conditions for the allotment of the 28,571,428 Conditional Subscription Shares detailed in the 29 January 2021 announcements.

 

The allotment of the Conditional Subscription Shares remains conditional, inter alia, upon approval by Shareholders of the Resolutions to be proposed at the General Meeting scheduled for 11.00 a.m. on 18 February 2021.

 

Application will be made for admission of the Conditional Subscription Shares to trading on AIM; it is expected that the Conditional Subscription Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 22 February 2021.

 

Total Voting Rights

Following Admission, the Company will have a total of 725,246,036 Ordinary Shares in issue with each Ordinary Share carrying the right of one vote. The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement released on 29 January 2021 unless the context requires otherwise.

 

For further information please contact:

 

 

MyHealthChecked plc

www.myhealthcheckedplc.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Maddy Kennedy, Chief Financial Officer

 

 

 

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

 

 

Oberon Investments (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus

Mob: +44(0)7980 541 893

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXAKFSXFEFA
Date   Source Headline
10th Nov 20255:30 pmRNSMyhealthchecked
10th Nov 20252:35 pmRNSChange of Company name - Replacement
10th Nov 202512:33 pmRNSChange of Company name
10th Nov 202511:00 amRNSCompletion of Disposal and Board Changes
4th Nov 20251:47 pmRNSResult of General Meeting
14th Oct 20258:00 amRNSProposed Sale of Concepta Diagnostics Limited
26th Sep 20257:00 amRNSHalf-year Report
31st Jul 20252:30 pmRNSResult of AGM
23rd Jul 20257:00 amRNSPartnership agreement with Patients Know Best
17th Jul 20257:00 amRNSSupply agreement with Boots for own-branded tests
30th Jun 20257:00 amRNSFinal Results
25th Apr 20257:00 amRNSPotential VAT reclaim – update
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 202511:11 amRNSHolding(s) in Company
14th Jan 20257:00 amRNS-RPhlebotomy tests registered in the UK and EU
23rd Dec 202411:56 amRNSExercise of Options
25th Nov 202410:11 amRNSHolding(s) in Company
1st Oct 202411:12 amRNSHolding(s) in Company
26th Sep 20247:00 amRNSHalf-year Report
24th Sep 202410:47 amRNSHolding(s) in Company
20th Sep 202411:21 amRNSHolding(s) in Company
12th Sep 20247:00 amRNSNotice of Results
28th Jun 202410:54 amRNSResult of AGM
4th Jun 20247:00 amRNSFinal Results & Notice of AGM
22nd May 20247:00 amRNSNotice of Results
10th May 20245:15 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSTrading Update
27th Dec 202312:58 pmRNSHolding(s) in Company
25th Sep 20231:13 pmRNSGrant of Options
19th Sep 20237:00 amRNSHalf-Year Report
4th Sep 20237:00 amRNSNotice of Results
8th Aug 20237:00 amRNSTrading update
26th Jul 20237:00 amRNSDirectorate Change
26th Jun 20237:00 amRNSDirectorate Change
18th May 20237:00 amRNSAgreement with Boots for extended retail launch
11th May 202311:19 amRNSResults of AGM and Share Consolidation
11th May 20237:00 amRNSAGM Statement
9th May 20238:36 amRNSStatement re. online comment
3rd May 20237:00 amRNSHealth Inspectorate Wales registration
12th Apr 20237:00 amRNSEstablishment of an Employee Benefit Trust
3rd Apr 20237:01 amRNSProposed Share Consolidation and Notice of AGM
3rd Apr 20237:00 amRNSPreliminary Results
29th Mar 202310:00 amRNSNotice of Results
31st Jan 20237:00 amRNSTrading Update
18th Jan 20237:01 amRNSConfirmation of Capital Reduction
18th Jan 20237:00 amRNSAppointment of Dowgate as Broker
6th Dec 202212:23 pmRNSResult of General Meeting
24th Nov 202210:37 amRNSDirector/PDMR Shareholding
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.